- DocumentoAn Introduction to Kinases and Kinase Inhibitorscaricato daBiotech Investors' Database
- DocumentoLa Transformation d'Oncodesign ... à Paris-Saclaycaricato daBiotech Investors' Database
- DocumentoOncodesign in Paris-Saclaycaricato daBiotech Investors' Database
- DocumentoThe Big Picture For Genfit_NASH+diabetes+CVDcaricato daBiotech Investors' Database
- DocumentoNo Doubt Genfit's Elafibranor cures Nashcaricato daBiotech Investors' Database
- DocumentoNew Genfit Data Challenge Placebo-Positive and Elafibranor-Negative Biopsy Interpretationscaricato daBiotech Investors' Database
- DocumentoL'Action Du GFT505 Sur Les Récepteurs Nucléaires PPARcaricato daBiotech Investors' Database
- DocumentoCellectis Demonstrates Potential of Allogenic CAR-T Technologycaricato daBiotech Investors' Database
- DocumentoThe Paradox of Obeticholic Acid for the Treatment of NASHcaricato daBiotech Investors' Database
- DocumentoGFT505, Genfit's PPAR Agonist for the Treatment of NASHcaricato daBiotech Investors' Database